BSE: 532540 NSE: Natco Pharma ISIN: INE467B01029 SECTOR: IT Software Company Company’s Website: IPO Date & Price: July 29, 2004 | Rs.
Natco Pharma Overview:
| Stock Symbol in NSE | Stock Symbol in BSE | Current Price | Market Cap. (Cr) | P/E Ratio | Current EPS |
|---|
Natco Pharma Sector Performance and Peer Comparison with Sector Analysis:
Did You Know?
<Space for Feature Image>
- Natco Pharma is the
- Its Belong to Group.
Balance Sheets & Profit & Loss Account:
| Year | Mar 2009 | Mar 2010 | Mar 2011 | Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 |
|---|
Natco Pharma Share Price Forecast Based on Current Growth +5/-5:
Share Price and EPS Forecast Based on Current Average Growth Rates:
| Next 5 Years (CG) | Next 10 Years (CG) | Next 20 Years (CG) |
|---|
Share Price and EPS Forecast Based on Current Average Growth Rates Plus 5%:
| Next 20 Years (CG+5%) | Next 10 Years (CG+5%) | Next 5 Years (CG+5%) |
|---|
Share Price and EPS Forecast Based on Current Average Growth Rates Minus 5%:
81100″]
Natco Pharma Quarterly Result, Date & Street Estimate:
| Share Name | Quarter Results | Year | Street Estimates | Profits | Growth |
|---|
Fundamental Analysis of Natco Pharma :
Natco Pharma Share Long Term Investment Price Target:
| Long Term Investment Tagets | Price | Qnt.Ratio |
|---|
Natco Pharma Fundamentals SWAT Analysis by AMT
Strengths, Weaknesses, Opportunities, and Threats of Natco Pharma
S
- Strengths Analysis will coming Soon.
W
- Weakness Analysis will coming Soon.
O
- Opportunity Analysis will coming Soon.
T
- Threats Analysis will coming Soon.
Where we can See Natco Pharma in Next 5 Year, 10 Year & 20 Year?
Technical Analysis of Natco Pharma :
Natco Pharma Share Weekly Swing Trading Price Target:
| Demand And Supply Zone | Support Levels | Support Price | Resistance Levels | Resistance Price |
|---|
Natco Pharma Share Today Intraday Price Target:
| IntradayTarget Today [Short Selling] | IntradayTarget Today [Long Buying] |
|---|
FAQ on Natco Pharma :
Yes, Natco Pharma is India Number-1 IT Software company, with lots business potential in next few year. Its Fundamentally strong Stock we recommend to buy at around 20-25 PE Ration price target. Anyway This company is quite famous for Good Dividends.
Natco Pharma is a Debt free company. Its can easily survived any down turn for 5-10 Quarter business growth.
Currently Natco Pharma is Trading at P/E Ratio which is
Both and working as a
Do to Covid-19 pandemic Natco Pharma Share drastically fall.
Its depend on when you and at what price you have buy this share, Natco Pharma at 20-25 P/E Ration is a excellent buy call for long Term Investment.
Natco Pharma ‘s Products/Projects:
| Products/Projects | Description/Valuation |
| A. | |
| B. | |
| C. |
IPO, Split, Bonus, Dividend Buyback History:
Natco Pharma First IPO was initiate on July 29, 2004. equity shares were put on sale during the IPO with a price band of Rs -Rs per equity share.
[ninja_tables id=”81105″
Company Profile:
| CEO Name | Rajeev Nannapaneni |
| CFO Name | Bhaskara Narayana Punyamurthula |
| CEO Salary | ₹ 4.3 Lakhs to ₹ 7.5 Lakhs. |
| Company Address | Mirza, Parlli Part, Assam 781122 |
| Contact Number | 080743 65626 +91-40-2354 7532 |
| Email Address | [email protected] |
Declaration: Investing in the Stock market is full of Risky. AllMoneyTips.COM doesn’t give any guarantee or warranted on its investment advice. Do your research before investing in the stock market. Our Forecast and buying selling levels of stocks is based on price action and demand and supply zone. There is no guarantee come with our prediction. Take it as advice only. We are not responsible for your losses on your investments.